The role of FDG PET/CT in the theranostic era
About this session
Join Dr. Daniel Pryma as he takes a deep dive into the history, current uses, and the future of theranostics. Learn more about several FDA-approved theranostic pairs and discover the advantages and disadvantages of using this technology to combat life-threatening diseases.
Daniel A. Pyrma
University of Pennsylvania, Philadelphia, USA
Related video sessions
The statements by Siemens Healthineers’ customers described herein are based on results that were achieved in the customer’s unique setting. Because there is no “typical” hospital or laboratory and many variables exist (e.g., hospital size, samples mix, case mix, level of IT and/or automation adoption) there can be no guarantee that other customers will achieve the same results.